SLC14A1

Chr 18

solute carrier family 14 member 1 (Kidd blood group)

Also known as: HUT11, HUT11A, HsT1341, JK, Jk(a), Jk(b), RACH1, RACH2

The protein encoded by this gene is a membrane transporter that mediates urea transport across cell membranes in erythrocytes and renal collecting ducts, facilitating the kidney's urinary concentrating mechanism. Mutations in SLC14A1 are associated with Kidd blood group variants, which primarily have clinical significance for blood transfusion compatibility rather than causing disease. The inheritance pattern follows typical Mendelian genetics for blood group systems.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

[Blood group, Kidd]MIM #111000
0
Active trials
13
Pubs (1 yr)
57
P/LP submissions
2%
P/LP missense
1.50
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySLC14A1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
53 unique Pathogenic / Likely Pathogenic· 47 VUS of 124 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.50LOEUF
pLI 0.000
Z-score -0.13
OE 1.03 (0.721.50)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.01Z-score
OE missense 1.00 (0.901.11)
246 obs / 245.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.03 (0.721.50)
00.351.4
Missense OE1.00 (0.901.11)
00.61.4
Synonymous OE1.01
01.21.6
LoF obs/exp: 20 / 19.4Missense obs/exp: 246 / 245.6Syn Z: -0.10
DN
0.77top 25%
GOF
0.78top 25%
LOF
0.2091th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

124 submitted variants in ClinVar

Classification Summary

Pathogenic49
Likely Pathogenic4
VUS47
Likely Benign5
Benign10
49
Pathogenic
4
Likely Pathogenic
47
VUS
5
Likely Benign
10
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
1
46
0
49
Likely Pathogenic
2
0
2
0
4
VUS
1
42
4
0
47
Likely Benign
0
3
2
0
5
Benign
0
6
0
4
10
Total552544115

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SLC14A1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →